BioSpace News Archive

CRH Medical Corporation, announces the following voting results for the Company’s 2019 Annual Meeting of Shareholders.

Chinese registrational clinical trial for lefamulin to begin in 2H 2019

In contract extension, Medical Home Network ACO takes financial risk and redesigns care for Medicaid beneficiaries

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the 2019 JMP Securities Life Sciences Conference

The Company also received confirmation of acceptance for its proposed endpoint for Phase III clinical trials from the U.S. FDA

Memorial Sloan Kettering Cancer Center is the world’s oldest and largest private cancer center

Company Urges Shareholders to Vote with the BLUE Card Online or By Phone

American Brachytherapy Society reinforces that those diagnosed with non-melanoma skin cancer can be treated with shorter, more targeted courses of radiation therapy using Skin HDR (High Dose Rate) Brachytherapy techniques.

Personalized, multi-channel outreach is Welltok’s “prescription” for success

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new host cell protein (HCP) kit for automated impurity analysis of biotherapeutics expressed in E. coli systems.